Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma

PHASE3CompletedINTERVENTIONAL
Enrollment

377

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

September 30, 2018

Study Completion Date

September 30, 2018

Conditions
Hemangioma
Interventions
DRUG

Propranolol

Initiated at a dosage of 1 mg/kg per day divided 3 times daily for 1 week, and then increased to 2 mg/kg per day divided 3 times daily from weeks 2 to 24.

DRUG

Atenolol

Initiated at a dosage of 0.5 mg/kg per day in a single dose for 1 week, and then increased to 1 mg/kg per day in a single dose from weeks 2 to 24.

Trial Locations (1)

610041

West China Hospital of Sichuan University, Chengdu

All Listed Sponsors
lead

West China Hospital

OTHER

NCT02342275 - Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma | Biotech Hunter | Biotech Hunter